ArticleCancer research communications2024

Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer.

Maira Soto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.